Compile Data Set for Download or QSAR
Report error Found 69 Enz. Inhib. hit(s) with all data for entry = 50010030
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090165(4-[2-((R)-4-Fluoro-3-fluoro-phenoxymethyl)-oxazol-...)
Affinity DataEC50:  2.30nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090150(4-[2-((R)-4-Fluoro-3-fluoro-benzyl)-oxazol-4-yl]-N...)
Affinity DataEC50:  4nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090170(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataEC50:  4.30nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090163(4-[2-((R)-4-Fluoro-benzyl)-oxazol-4-yl]-N-{4-[2-(2...)
Affinity DataEC50:  5.20nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090155(4-[2-(3-Cyclopentyl-propyl)-oxazol-5-yl]-N-{(R)-4-...)
Affinity DataEC50:  5.30nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090161(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  9.20nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090157(4-[2-(3,4-Difluoro-benzyl)-oxazol-5-yl]-N-{4-[2-((...)
Affinity DataEC50:  11nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090160(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  12nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090153(4-[2-((R)-2-Cyclopentyl-ethyl)-oxazol-5-yl]-N-{4-[...)
Affinity DataEC50:  14nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090158(4-[2-((R)-2-Cyclopentyl-ethyl)-oxazol-4-yl]-N-{4-[...)
Affinity DataEC50:  15nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090149(4-(2-Cyclopentylmethyl-oxazol-5-yl)-N-{(R)-4-[2-(2...)
Affinity DataEC50:  19nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090152(4-[2-((R)-4-Fluoro-phenoxymethyl)-oxazol-4-yl]-N-{...)
Affinity DataEC50:  19nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090151(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  22nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090169(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  26nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090154(4-(2-Hexyl-oxazol-5-yl)-N-{4-[2-((R)-2-hydroxy-2-p...)
Affinity DataEC50:  34nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090162(4-[2-(3,4-Difluoro-phenyl)-oxazol-5-yl]-N-{(R)-4-[...)
Affinity DataEC50:  35nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090148(4-[2-((R)-4-Fluoro-3-fluoro-phenyl)-oxazol-4-yl]-N...)
Affinity DataEC50:  35nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090164(4-[2-((R)-4-Fluoro-phenyl)-oxazol-5-yl]-N-{4-[2-(2...)
Affinity DataEC50:  37nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090167(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  39nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090156(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  76nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090159(BN-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)...)
Affinity DataEC50: >100nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090169(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 200nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090166(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataEC50:  210nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090168(4-[2-((R)-4,4-Dimethyl-pentyl)-oxazol-5-yl]-N-{4-[...)
Affinity DataEC50:  230nMAssay Description:In vitro efficacy at beta-3 adrenoceptors, quantified by measuring intracellular cAMP.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090160(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 270nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090170(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataIC50: 310nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090155(4-[2-(3-Cyclopentyl-propyl)-oxazol-5-yl]-N-{(R)-4-...)
Affinity DataIC50: 320nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090160(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 350nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090150(4-[2-((R)-4-Fluoro-3-fluoro-benzyl)-oxazol-4-yl]-N...)
Affinity DataIC50: 630nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090161(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 940nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090155(4-[2-(3-Cyclopentyl-propyl)-oxazol-5-yl]-N-{(R)-4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090168(4-[2-((R)-4,4-Dimethyl-pentyl)-oxazol-5-yl]-N-{4-[...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090170(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataIC50: 1.20E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090154(4-(2-Hexyl-oxazol-5-yl)-N-{4-[2-((R)-2-hydroxy-2-p...)
Affinity DataIC50: 1.20E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090151(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 1.40E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090153(4-[2-((R)-2-Cyclopentyl-ethyl)-oxazol-5-yl]-N-{4-[...)
Affinity DataIC50: 1.80E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090148(4-[2-((R)-4-Fluoro-3-fluoro-phenyl)-oxazol-4-yl]-N...)
Affinity DataIC50: 1.90E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090158(4-[2-((R)-2-Cyclopentyl-ethyl)-oxazol-4-yl]-N-{4-[...)
Affinity DataIC50: 2.00E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090168(4-[2-((R)-4,4-Dimethyl-pentyl)-oxazol-5-yl]-N-{4-[...)
Affinity DataIC50: 2.00E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090161(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 2.00E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090151(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 2.10E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090148(4-[2-((R)-4-Fluoro-3-fluoro-phenyl)-oxazol-4-yl]-N...)
Affinity DataIC50: 2.20E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090150(4-[2-((R)-4-Fluoro-3-fluoro-benzyl)-oxazol-4-yl]-N...)
Affinity DataIC50: 2.40E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090149(4-(2-Cyclopentylmethyl-oxazol-5-yl)-N-{(R)-4-[2-(2...)
Affinity DataIC50: 2.50E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090159(BN-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)...)
Affinity DataIC50: 3.00E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090162(4-[2-(3,4-Difluoro-phenyl)-oxazol-5-yl]-N-{(R)-4-[...)
Affinity DataIC50: 3.00E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-1 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090167(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 3.00E+3nMAssay Description:In vitro binding affinity at beta-1 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090163(4-[2-((R)-4-Fluoro-benzyl)-oxazol-4-yl]-N-{4-[2-(2...)
Affinity DataIC50: 3.30E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090165(4-[2-((R)-4-Fluoro-3-fluoro-phenoxymethyl)-oxazol-...)
Affinity DataIC50: 3.50E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50090167(N-{(R)-4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataIC50: 3.50E+3nMAssay Description:In vitro binding affinity at beta-2 adrenergic receptors in the presence of [125I]iodocyanopindolol.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 69 total ) | Next | Last >>
Jump to: